[HTML][HTML] Botulinum toxin in the management of children with cerebral palsy
… limbs of children with cerebral palsy will result in a predictable … in the developing foetal or
infant brain. The motor disorders of … in developed countries [27, 31]. A widely used definition of …
infant brain. The motor disorders of … in developed countries [27, 31]. A widely used definition of …
[HTML][HTML] IncobotulinumtoxinA for the treatment of spasticity in children with cerebral palsy–a retrospective case series focusing on dosing and tolerability
A León-Valenzuela, JS Palacios, R del Pino Algarrada - BMC neurology, 2020 - Springer
… IncobotulinumtoxinA (Xeomin®) is a botulinum neurotoxin type … case series included children
with a diagnosis of infantile … On the other hand, one of the main adverse effects reflected is …
with a diagnosis of infantile … On the other hand, one of the main adverse effects reflected is …
[HTML][HTML] Botulinum toxin treatment for limb spasticity in childhood cerebral palsy
V Pavone, G Testa, DA Restivo, L Cannavò… - Frontiers in …, 2016 - frontiersin.org
… We include techniques for administration, side effects, and … The etiologic events act in an
early phase of fetal and infant cerebral … to be responsible for most cases of resistance. Using the …
early phase of fetal and infant cerebral … to be responsible for most cases of resistance. Using the …
Safety and efficacy of Botulinum toxin type A preparations in cerebral palsy—an evidence-based review
M Bonikowski, J Sławek - Neurologia i Neurochirurgia Polska, 2021 - journals.viamedica.pl
… in the developing foetal or infant brain” [1]. CP is the main cause … [27] published a systematic
review of RCTs of BoNT-A … The effects of quantitative gait assessment and botulinum toxin a …
review of RCTs of BoNT-A … The effects of quantitative gait assessment and botulinum toxin a …
[HTML][HTML] A prospective study investigating gross motor function of children with cerebral palsy and GMFCS level II after long-term botulinum toxin type A use
J Valentine, SA Davidson, N Bear, E Blair, L Paterson… - BMC pediatrics, 2020 - Springer
… in the developing fetal or infant brain’ [1, 2]. The Australian … -term outcomes of interventions
for children with CP [27, 28]. … compared the score to the predicted GMFM-66 score for the …
for children with CP [27, 28]. … compared the score to the predicted GMFM-66 score for the …
Effect of botulinum toxin type-A in spasticity and functional outcome of upper limbs in cerebral palsy
S Yadav, S Chand, R Majumdar, A Sud - Journal of clinical orthopaedics …, 2020 - Elsevier
… the developing fetal or infant brain’‘. Although the brain lesion in … effects of BTX-A in treatment
of upper limb spasticity in … Published large systemic reviews26, 27, 28 agree on the finding …
of upper limb spasticity in … Published large systemic reviews26, 27, 28 agree on the finding …
Adverse drug reactions of botulinum neurotoxin type A in children with cerebral palsy: a pharmaco‐epidemiological study in VigiBase
J Montastruc, P Marque, F Moulis… - … Medicine & Child …, 2017 - Wiley Online Library
… The most frequent ADR was dysphagia (27 ICSRs, 17%) … In these studies, adverse effects
were spontaneously … CP (ie diplegia, quadriplegia, infantile hemiplegia). We excluded …
were spontaneously … CP (ie diplegia, quadriplegia, infantile hemiplegia). We excluded …
Safety and Efficacy of Botulinum Toxin Type A in Children With Spastic Cerebral Palsy Aged< 2 Years: A Systematic Review
H Yang, S Chen, J Shen, Y Chen… - Journal of Child …, 2023 - journals.sagepub.com
… In one such case, it was reported that the patient's symptoms gradually improved after 6 …
In the studies conducted by Du et al 24 and Zhou et al, 27 ADL was assessed; the results …
In the studies conducted by Du et al 24 and Zhou et al, 27 ADL was assessed; the results …
[HTML][HTML] Botulinum toxin intervention in cerebral palsy-induced spasticity management: projected and contradictory effects on skeletal muscles
… control system in the developing fetal or infant brain [31,32]. … The spastic type of CP accounts
for 77–86% of all cases [35,… changes in intramuscular connective tissues [27,79], many …
for 77–86% of all cases [35,… changes in intramuscular connective tissues [27,79], many …
[HTML][HTML] Botulinum toxin intervention in cerebral palsy-induced spasticity management: projected and contradictory effects on skeletal muscles
CS Kaya Keles, F Ates - Toxins, 2022 - mdpi.com
… control system in the developing fetal or infant brain [31,32]. … The spastic type of CP accounts
for 77–86% of all cases [35,… changes in intramuscular connective tissues [27,79], many …
for 77–86% of all cases [35,… changes in intramuscular connective tissues [27,79], many …